Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Nagy Mekhail, MD, PhD, holds a joint appointment at the Cleveland Clinic Spine Center and Cleveland Clinic Cancer Center. He is also Professor of Anesthesiology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve. His treatment interests include pain management, interventional spine pain management, cancer pain and neuropathic pain.
Dr. Mekhail is a member of the Pain Committee of the American Society of Anesthesiologists (ASA), Member of the American Pain Society Palliative Care Special Interest Group, Member of the Board of Directors World Institute of Pain and Examiner for the World Institute of Pain Practice Exam. He is also a member of the Oversight Committee for the Annual American Society of Anesthesiologists Meeting Regional Anesthesia and Pain Medicine (ASRA) and part of the Task Force for "Industry Relations."
He is also a member of the American Academy of Pain Medicine, an Executive Board member of the World Institute of Pain, Chair of the Interventional Pain Practice Examination Board of the World Institute of Pain, and an ASA Adjunct Member of the Committee on Pain Medicine and Committee on Physician Resources. He is a member of the Society for Anesthesia Education Committee for the Journal of Education in Perioperative Medicine.
Dr. Mekhail is the former Chair of the Pain Management Fellowship Directors Committee on Training Curriculum of the American Association of Pain Management Program Directors. He is also the former Co-Chair of a Pain Management Fellowship Directors Round Table Discussion on incorporating interventional pain therapy in training fellowship programs.
He is a former member of the American Academy of Pain Medicine Annual program Committee, former ASA Adjunct Member of the Committee on Physician Resources, former member of the American Academy of Pain Medicine Scientific Review Committee. He also is a former member of the American Society of Regional Anesthesia Research Committee, Review Course Chair of the American Academy of Pain Medicine Program Committee, a participant in the ASA Refresher Course Lectures/Basic Science Review on Pain Management and Scientific Symposia Chair of the American Academy of Pain Medicine Program Committee.
He became a Diplomate of American Board of Anesthesiology and Diplomate of American Board of Anesthesiology, with added qualifications in Pain Management in 1993 and was recertified in 2004. He became a Fellow of the Interventional Pain Practice in 2001.
Evaluation of back and neck pain, interventional pain management for back and neck pain, with special interest in the management of spinal stenosis and vertebral compression fractures, cancer pain evaluation and management, neuropathic, neuropathic pain, pelvic pain,Neuromodulation and interspinal drug delivery of pain and spasticity, research, spine, spine pain
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/27/2015, Dr. Mekhail has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.